Reference number : 236-2018-2019-Q1-00602, amendment number : , agreement type : G, recipient legal name : Moodley, Serisha, recipient country : CA, recipient province : ON, recipient city : Kingston, recipient postal code : K7L 3N6, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 135000.0, agreement start date : 2018-04-01, agreement end date : 2021-03-31, description english : In Vivo Characterization of novel RET Tyrosine Kinase-targeting Inhibitors as Therapeutic Options for Lung Adenocarcinoma, description french : In Vivo Characterization of novel RET Tyrosine Kinase-targeting Inhibitors as Therapeutic Options for Lung Adenocarcinoma, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada